Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EBS Emergent Biosolutions

未开盘 04-25 16:00:00 EDT

1.95

-0.23

-10.55%

盘后2.00

+0.05+2.56%

19:52 EDT

最高2.13	最低1.95	成交量109.32万
今开2.12	昨收2.18	日振幅8.17%
总市值1.02亿	流通市值1.01亿	总股本5,239万
成交额218.26万	换手率2.12%	流通股本5,168万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EBS","market":"US","secType":"STK","nameCN":"Emergent Biosolutions","latestPrice":1.95,"timestamp":1714075200000,"preClose":2.18,"halted":0,"volume":1093229,"hourTrading":{"tag":"盘后","latestPrice":2,"preClose":1.95,"latestTime":"19:52 EDT","volume":15489,"amount":30857.2853,"timestamp":1714089155435},"delay":0,"floatShares":51684646,"shares":52390764,"eps":-14.853515,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.23,"latestTime":"04-25 16:00:00 EDT","open":2.12,"high":2.1282,"low":1.95,"amount":2182635.0875099,"amplitude":0.081743,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-14.853515,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714118400000},"adr":0,"listingDate":1254456000000,"adjPreClose":2.18,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.15,"preClose":2.18,"latestTime":"09:28 EDT","volume":185,"amount":396.66510450000004,"timestamp":1714051710172},"postHourTrading":{"tag":"盘后","latestPrice":2,"preClose":1.95,"latestTime":"19:52 EDT","volume":15489,"amount":30857.2853,"timestamp":1714089155435},"volumeRatio":1.081939},"requestUrl":"/m/hq/s/EBS","defaultTab":"news","newsList":[{"id":"2430286112","title":"Emergent Biosolutions, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286112","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286112?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:42","pubTimestamp":1714052524,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时42分，Emergent Biosolutions, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报2.07美元/股，成交量4.2042万股，换手率0.08%，振幅2.67%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体跌幅为0.23%。其相关个股中，Optinose, Inc.、Biofrontera Inc C/Wts 27/10/2026 、阿斯利康涨幅较大，Sunshine Biopharma Inc.、Optinose, Inc.、Fsd Pharma Inc.较为活跃，换手率分别为772.49%、9.03%、1.39%，振幅较大的相关个股有Optinose, Inc.、Fsd Pharma Inc.、Organogenesis Holdings Inc.，振幅分别为16.21%、15.20%、13.08%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214204861e90af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214204861e90af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429945390","title":"BUZZ-美国食品和药物管理局（FDA）批准非处方用药过量逆转鼻腔喷雾剂，Amneal 公司业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2429945390","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429945390?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:55","pubTimestamp":1713963351,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月24日 - ** Amneal制药公司  股价盘前上涨11%，报5.99美元 ** 公司称美国食品和药物管理局已批准其非处方药盐酸纳洛酮鼻喷雾剂用于阿片类药物过量的紧急治疗** 公司称其盐酸纳洛酮鼻喷雾剂现已在美国上市 ** AMRX公司的喷雾剂是Emergent Biosolutions公司  纳洛酮鼻用喷雾剂的仿制药，后者于2023年获准在没有处方的情况下销售。 ** 截至上次收盘，AMRX年累计下跌约11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429538118","title":"Emergent Biosolutions, Inc.盘中异动 早盘股价大涨5.09%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429538118","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429538118?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:47","pubTimestamp":1713880062,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时47分，Emergent Biosolutions, Inc.股票出现异动，股价快速拉升5.09%。截至发稿，该股报2.27美元/股，成交量5.7916万股，换手率0.11%，振幅6.48%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为0.47%。其相关个股中，Scynexis, Inc.、Esperion Therapeutics, Inc.、Procaps Group, S.A.涨幅较大，Sunshine Biopharma Inc.、苏轩堂、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为140.31%、9.76%、4.69%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Cbdmd, Inc.、脑再生科技，振幅分别为16.94%、14.98%、13.82%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232147437a54ee17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232147437a54ee17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429197162","title":"Emergent Biosolutions, Inc.盘中异动 大幅拉升5.30%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429197162","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429197162?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:02","pubTimestamp":1713805350,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日01时02分，Emergent Biosolutions, Inc.股票出现波动，股价急速拉升5.30%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为1.24%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Evoke Pharma, Inc.涨幅较大，Sunshine Biopharma Inc.、苏轩堂、Akanda Corp.较为活跃，换手率分别为382.81%、42.11%、39.45%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、Biofrontera Inc.、Fsd Pharma Inc.，振幅分别为59.26%、19.17%、17.14%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230102307a549de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230102307a549de2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428657656","title":"Emergent Biosolutions, Inc.盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428657656","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428657656?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:07","pubTimestamp":1713535623,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时07分，Emergent Biosolutions, Inc.股票出现波动，股价急速上涨5.11%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体跌幅为0.19%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Scilex Holding Company C/Wts 10/11/2027 、Akanda Corp.涨幅较大，Sunshine Biopharma Inc.、苏轩堂、Akanda Corp.较为活跃，换手率分别为589.40%、38.35%、11.08%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Akanda Corp.、Sunshine Biopharma Inc.，振幅分别为45.65%、18.07%、15.36%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192207037a541edc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192207037a541edc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426257663","title":"Benchmark：重申Emergent BioSolutions(EBS.US)评级，由买入调整至买入评级, 目标价5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426257663","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426257663?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:16","pubTimestamp":1712841368,"startTime":"0","endTime":"0","summary":"Benchmark：重申Emergent BioSolutions(EBS.US)评级，由买入调整至买入评级, 目标价5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112116138b107ed9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112116138b107ed9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421986729","title":"飞行汽车“热辣滚烫”，万安科技股价真的能“支棱”起来吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2421986729","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2421986729?lang=zh_cn&edition=full","pubTime":"2024-03-22 17:55","pubTimestamp":1711101326,"startTime":"0","endTime":"0","summary":"2023年，万安科技以两位数的增长态势，领先同行。1月30日，万安科技公告，控股子公司安徽万安收到国内某知名飞行汽车公司出具的《定点开发通知书》，安徽万安被客户选定为某车型前副车架总成产品的供应商，要求安徽万安与其技术、质量部门对接，进行图纸、数据的确认并签订合同。在飞行汽车概念加持之下，万安科技股价真的能“支棱”起来吗？其中，气压制动系统和液压制动系统是万安科技的两大拳头产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/229329","is_publish_highlight":false,"gpt_icon":0},{"id":"2418301985","title":"《汇市简讯》欧元/美元技术面看涨，支撑位上移","url":"https://stock-news.laohu8.com/highlight/detail?id=2418301985","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418301985?lang=zh_cn&edition=full","pubTime":"2024-03-12 16:16","pubTimestamp":1710231397,"startTime":"0","endTime":"0","summary":"0808GMT   * 欧元/美元从2月的1.0695回升(EBS)，彰显看涨行情   * 一直在不断增厚的云区支撑上方交易，目前云区在1.0848-1.0931   * 14天动能保持良好，巩固了整体看涨行情   * 整体涨势有初步测试1月11日1.1000高点的空间   * 若升破1.1000高点，将上看12月高点1.1139   * 我们寻求在1.0935做多，目标 1.1135   * 美","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417822726","title":"Emergent BioSolutions 公司报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2417822726","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417822726?lang=zh_cn&edition=full","pubTime":"2024-03-07 07:57","pubTimestamp":1709769423,"startTime":"0","endTime":"0","summary":"   * Emergent BioSolutions Inc   报告，截至12月底的季度调整后每股亏损77美分，低于去年同期的每股收益-31美分。* 营收同比下降 16.4%，至 2.766 亿美元；分析师预期为 2.9353 亿美元。* Emergent BioSolutions 公司公布的本季度每股收益为亏损 95 美分。* 该公司的季度亏损额为 4950 万美元。* 本季度，Emergent BioSolutions Inc 的股价上涨了 42.1%。华尔街对 Emergent BioSolutions Inc 的 12 个月目标价中位数为 5.50 美元。本摘要由 LSEG 于世界协调时 3 月 6 日晚上 11:56 的数据机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413740971","title":"Emergent BioSolutions Inc   预计每股亏损19美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413740971","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413740971?lang=zh_cn&edition=full","pubTime":"2024-02-24 11:08","pubTimestamp":1708744082,"startTime":"0","endTime":"0","summary":"   * Emergent BioSolutions Inc    将于2月26日公布截至2023年12月31日的财报(估计)，预计该公司的季度收入将出现下降。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于马里兰州盖瑟斯堡的公司的营收将从去年同期的3.307亿美元降至2.93533亿美元，降幅为11.2%。)   * LSEG 分析师对 Emergent BioSolutions Inc 的平均预期是每股亏损 19 美分。* 华尔街对 Emergent BioSolutions Inc 的 12 个月目标价中位数为 5.50 美元，高于其最新收盘价 2.74 美元。2月24日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413420708","title":"嗡嗡声--美国股票走势-Toll Brothers、Natgas 公司、Eton 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2413420708","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413420708?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:55","pubTimestamp":1708530942,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月21日 - 华尔街周三下跌，因为投资者在等待芯片设计公司英伟达的高风险财报，如果财报不尽如人意，可能会阻碍今年的人工智能热潮。美东时间10:33，道琼斯工业平均指数  下跌0.24%，报38472.83点。标准普尔500指数  下跌0.26%，报4,962.55点；纳斯达克综合指数  下跌0.62%，报15,533.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413450447","title":"BUZZ-任命前博士伦高管为首席执行官后，Emergent 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2413450447","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413450447?lang=zh_cn&edition=full","pubTime":"2024-02-21 20:57","pubTimestamp":1708520254,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    2月21日 - ** Emergent BioSolutions   股价在盘前交易中上涨17.8%，至1.79美元 ** 该公司称 (link)，已任命 Joseph Papa 为新任首席执行官，自 2 月 21 日起生效** Papa 最近曾担任博士伦    的首席执行官兼董事长。** 海伍德-米勒将辞去临时首席执行官一职** 截至上次收盘，股价在过去 12 个月中下跌了 90.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413447315","title":"更新版 1-Emergent 任命前博士伦首席执行官领导公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2413447315","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413447315?lang=zh_cn&edition=full","pubTime":"2024-02-21 20:35","pubTimestamp":1708518936,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (第2段增加了股份变动情况，第3、4段增加了背景情况)    路透社2月21日 - Emergent BioSolutions   周三表示，已任命博士伦  前首席执行官约瑟夫-帕帕（Joseph Papa）为这家生命科学公司的负责人，2月21日生效。该公司股价在收盘前上涨了近5%。Papa在医疗保健行业拥有35年的经验，最近曾担任全球眼科保健公司博士伦的首席执行官兼董事长。在过去的 12 个月里，Emergent 的股价下跌了约 90%，8 月份创下了 16 年来的新低，原因是该公司的合同研究业务疲软。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413444015","title":"Emergent 任命约瑟夫-帕帕（Joseph Papa）为新任首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2413444015","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413444015?lang=zh_cn&edition=full","pubTime":"2024-02-21 20:06","pubTimestamp":1708517198,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社2月21日 - Emergent BioSolutions   周三表示，它已任命博士伦  前首席执行官约瑟夫-帕帕（Joseph Papa）担任这家生命科学公司的负责人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409700571","title":"《汇市简讯》美元/日圆创10月来最大涨幅后，关注费波纳奇回档位","url":"https://stock-news.laohu8.com/highlight/detail?id=2409700571","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409700571?lang=zh_cn&edition=full","pubTime":"2024-02-05 17:04","pubTimestamp":1707123869,"startTime":"0","endTime":"0","summary":"0848GMT   * 美元/日圆上周五创下10月以来最大单日涨幅   * 14天动能指标仍为正，强化了看涨倾向   * 关注11月-12月跌势151.92-140.27的76.4%费波纳奇回档位149.17    * 美元/日圆仍持于日线云区和关键的费波纳奇回档位149.17之间   * 日线云区目前位于143.58-146.10区域   * 根据EBS数据，截至目前为止欧元/日圆在159.84-160.27区间波动    * 更多汇市简讯请点选  (Martin Miller是路透的市场分析师。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402473384","title":"BUZZ--美国股票走势-美国航空公司、石油公司、Salesforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2402473384","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402473384?lang=zh_cn&edition=full","pubTime":"2024-01-11 22:13","pubTimestamp":1704982434,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月11日 - 追踪华尔街主要指数的期货周四转为负面，因为消费者通胀率高于预期，抑制了提前开始降息的预期。美东时间9:01，道指电子盘  下跌0.23%，报37847点。标普500指数小型股  下跌0.24%，报4,808.75点；纳斯达克100指数小型股  下跌0.16%，报16,917.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2394784706","title":"瑞立科密冲刺深交所：年营收13亿 拟募资16亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2394784706","media":"雷递","top":-1,"share":"https://www.laohu8.com/m/news/2394784706?lang=zh_cn&edition=full","pubTime":"2023-12-27 18:49","pubTimestamp":1703674140,"startTime":"0","endTime":"0","summary":"招股书显示，瑞立科密2020年、2021年、2022年营收分别为12.71亿元、13.83亿元、13.26亿元；净利分别为2.48亿元、2亿元、1.05亿元；扣非后净利分别为1.9亿元、1.4亿元、8069.95万元。瑞立科密2023年上半年营收为7.93亿元，净利为1.29亿元，扣非后净利为1.24亿元。整体来看，过去2年，瑞立科密营收增长停止，利润处于持续下滑状态。张晓平家族控制72%股权瑞立科密控股股东为瑞立集团。张晓平、池淑萍、张佳睿合计控制瑞立科密71.5614%的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzQ5NjIyMQ==&mid=2661607570&idx=8&sn=312692169c01e5b15d3ad72dca48d8db&chksm=bc74d0335d0728ed567487d6d4349531a1756f5fb13067d06702da00b8d7fd9ab32bc3edc2b6&scene=0#rd","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.emergentbiosolutions.com","stockEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":-0.2008},{"period":"3month","weight":0.0714},{"period":"6month","weight":-0.025},{"period":"1year","weight":-0.7831},{"period":"ytd","weight":-0.1875}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Emergent Biosolutions Inc.是一家专业制药公司，向医疗保健提供商和政府提供专门的产品寻求保护和提高生活品质，用于解决医疗需要和新出现的健康威胁。该公司是1998年5月在美国密歇根州成立的，随后在 2004年6月改为特拉华公司。公司拥有两个经营部门：生物防卫和生物科学。","yearOnYearQuotes":[{"month":1,"riseRate":0.722222,"avgChangeRate":0.041439},{"month":2,"riseRate":0.444444,"avgChangeRate":0.018478},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.017909},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.041538},{"month":5,"riseRate":0.529412,"avgChangeRate":-0.006031},{"month":6,"riseRate":0.588235,"avgChangeRate":0.001177},{"month":7,"riseRate":0.588235,"avgChangeRate":0.072632},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.023732},{"month":9,"riseRate":0.294118,"avgChangeRate":-0.04254},{"month":10,"riseRate":0.529412,"avgChangeRate":0.003652},{"month":11,"riseRate":0.588235,"avgChangeRate":-0.003104},{"month":12,"riseRate":0.611111,"avgChangeRate":0.046155}],"exchange":"NYSE","name":"Emergent Biosolutions","nameEN":"Emergent BioSolutions"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Emergent Biosolutions,EBS,Emergent Biosolutions股票,Emergent Biosolutions股票老虎,Emergent Biosolutions股票老虎国际,Emergent Biosolutions行情,Emergent Biosolutions股票行情,Emergent Biosolutions股价,Emergent Biosolutions股市,Emergent Biosolutions股票价格,Emergent Biosolutions股票交易,Emergent Biosolutions股票购买,Emergent Biosolutions股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}